Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Mediators Inflamm ; 2019: 3496836, 2019.
Article in English | MEDLINE | ID: mdl-31015795

ABSTRACT

OBJECTIVE: Ischemia-reperfusion injury (IRI) produces systemic inflammation with the potential for causing organ failure in tissues peripheral to the initial site of injury. We speculate that treatment strategies that dampen inflammation may be therapeutically beneficial to either the initial site of injury or peripheral organs. To test this, we evaluated the impact of FTY720-induced sequestration of circulating mature lymphocytes on renal IRI and secondary organ injury. METHODS: A microvascular clamp was surgically placed around the left renal pedicle of anesthetized male Sprague-Dawley rats with either vehicle or FTY720 treatment (0.3 mg/kg) intravenously injected after 15 min of ischemia. Blood flow was restored after 60 min. Cohorts of anesthetized rats were euthanized at 6, 24, or 72 hrs with tissue samples collected for analysis. RESULTS: FTY720 treatment resulted in profound T lymphocyte reduction in peripheral blood. Histopathologic examination, clinical chemistries, and gene transcript expression measurements revealed that FTY720 treatment reduced hepatocellular degeneration, reduced serum markers of liver injury (ALT/AST), and reduced the expression of gene targets associated with IRI. CONCLUSION: These findings support an anti-inflammatory effect of FTY720 in the liver where the expression of genes associated with apoptosis, chemotaxis, and the AP-1 transcription factor was reduced. Findings presented here provide the basis for future studies evaluating FTY720 as a potential therapeutic agent to treat complications resulting from renal IRI.


Subject(s)
Fingolimod Hydrochloride/therapeutic use , Inflammation/drug therapy , Kidney Diseases/drug therapy , Animals , Disease Models, Animal , Kidney/drug effects , Kidney/metabolism , Kidney/pathology , Kidney Diseases/metabolism , Liver/drug effects , Liver/metabolism , Male , Rats , Rats, Sprague-Dawley , Reperfusion Injury , Transcription Factor AP-1/metabolism
2.
PLoS One ; 13(11): e0208249, 2018.
Article in English | MEDLINE | ID: mdl-30496326

ABSTRACT

Beyond its anti-fibrinolytic mechanism, tranexamic acid has been suggested to have anti-inflammatory properties which may contribute to the survival benefit it provides to trauma patients. The objective of this study was to assess possible immunomodulatory effects of tranexamic acid as well as potential amelioration of end-organ injury in a rodent hemorrhagic shock model. Controlled hemorrhagic shock was induced in adult Sprague Dawley rats to a mean arterial pressure of 30 mmHg. Groups of 10 rats were administered intravenous tranexamic acid (300mg/kg) or vehicle control (normal saline) intravenously 15 minutes after the induction of shock. After 60 minutes of hemorrhagic shock, resuscitation was started. Animals were euthanized at six, 24, or 72 hours from the start of shock. Serum laboratory values to include inflammatory biomarkers were measured, and end organ histology was evaluated. Tranexamic acid treatment was associated with a significant decrease in serum IL-1ß at six and 24 hours and IL-10 at 24 hours from start of shock compared to vehicle control. Histologic analysis demonstrated mild decreases in both perivascular pulmonary edema and follicular mesenteric lymph node hyperplasia in the tranexamic acid treatment group but also increased myocardial lymphocytic infiltration with necrosis and degeneration. Tranexamic acid was also associated with a small but significant increase in peripheral neutrophil count as well as a significant decrease in neutrophil aggregation in pulmonary tissue at six hours post-injury. These data thus demonstrate a mixed effect of tranexamic acid. While there was an improvement in pulmonary edema and a suppressive effect on several key inflammatory mediators, there was also increased myocardial degeneration and necrosis, which is possibly related to the pro-thrombotic effect of tranexamic acid.


Subject(s)
Antifibrinolytic Agents/therapeutic use , Inflammation/drug therapy , Shock, Hemorrhagic/drug therapy , Tranexamic Acid/therapeutic use , Animals , Inflammation/blood , Inflammation/etiology , Inflammation/pathology , Lung/drug effects , Lung/pathology , Lymph Nodes/drug effects , Lymph Nodes/pathology , Male , Myocardium/pathology , Rats, Sprague-Dawley , Resuscitation/methods , Shock, Hemorrhagic/blood , Shock, Hemorrhagic/complications , Shock, Hemorrhagic/pathology
3.
Methods Mol Biol ; 1773: 73-91, 2018.
Article in English | MEDLINE | ID: mdl-29687382

ABSTRACT

Murine models of allograft transplantation are valuable for understanding the immunological mechanisms of allograft acceptance and rejection, the evaluation of immunosuppressive drugs and strategies, and the restoration of functional defects. Herein, we describe methods to create a skin murine allograft surgical model and how to administer adipose-derived stromal cells (ASC) with limited numbers of donor bone marrow to create stable multilineage donor cell chimerism and indefinite immunological tolerance.


Subject(s)
Mesenchymal Stem Cells/cytology , Skin Transplantation , Transplantation Chimera/immunology , Transplantation Tolerance/immunology , Allografts/immunology , Animals , Bone Marrow Cells/cytology , Bone Marrow Cells/immunology , Female , Humans , Mesenchymal Stem Cells/immunology , Mice , Mice, Inbred BALB C , Mice, Inbred C3H , Mice, Inbred C57BL , Models, Animal , Transplantation, Homologous
4.
Mediators Inflamm ; 2017: 4594035, 2017.
Article in English | MEDLINE | ID: mdl-29410598

ABSTRACT

Acute ischemia-reperfusion injury (IRI) of the extremities leads to local and systemic inflammatory changes which can hinder limb function and can be life threatening. This study examined whether the administration of the T-cell sequestration agent, FTY720, following hind limb tourniquet-induced skeletal muscle IRI in a rat model would attenuate systemic inflammation and multiple end organ injury. Sprague-Dawley rats were subjected to 1 hr of ischemia via application of a rubber band tourniquet. Animals were randomized to receive an intravenous bolus of either vehicle control or FTY720 15 min after band placement. Rats (n = 10/time point) were euthanized at 6, 24, and 72 hr post-IRI. Peripheral blood as well as lung, liver, kidney, and ischemic muscle tissue was analyzed and compared between groups. FTY720 treatment markedly decreased the number of peripheral blood T cells (p < 0.05) resulting in a decreased systemic inflammatory response and lower serum creatinine levels and had a modest but significant effect in decreasing the transcription of injury-associated target genes in multiple end organs. These findings suggest that early intervention with FTY720 may benefit the treatment of IRI of the limb. Further preclinical studies are necessary to characterize the short-term and long-term beneficial effects of FTY720 following tourniquet-induced IRI.


Subject(s)
Extremities/blood supply , Fingolimod Hydrochloride/therapeutic use , Inflammation/drug therapy , Reperfusion Injury/drug therapy , Animals , CD4-Positive T-Lymphocytes/drug effects , Male , Rats , Rats, Sprague-Dawley , Reperfusion Injury/immunology , Tourniquets
5.
Aging health ; 7(5): 707-718, 2011 Oct 01.
Article in English | MEDLINE | ID: mdl-22121388

ABSTRACT

The incidence of most common cancers increases with age. This occurs in association with, and is possibly caused by a decline in immune function, termed immune senescence. Although the size of the T-cell compartment is quantitatively maintained into older age, several deleterious changes (including significant changes to T-cell subsets) occur over time that significantly impair immunity. This article highlights some of the recent findings regarding the aging immune system, with an emphasis on the T-cell compartment and its role in cancer.

6.
J Immunol ; 186(11): 6238-54, 2011 Jun 01.
Article in English | MEDLINE | ID: mdl-21531893

ABSTRACT

The transfer of unfractionated DBA/2J (DBA) splenocytes into B6D2F(1) (DBA → F(1)) mice results in greater donor CD4 T cell engraftment in females at day 14 that persists long-term and mediates greater female lupus-like renal disease. Although donor CD8 T cells have no demonstrated role in lupus pathogenesis in this model, we recently observed that depletion of donor CD8 T cells prior to transfer eliminates sex-based differences in renal disease long-term. In this study, we demonstrate that greater day 14 female donor CD4 engraftment is also critically dependent on donor CD8 T cells. Male DBA → F(1) mice exhibit stronger CD8-dependent day 8-10 graft-versus-host (GVH) and counter-regulatory host-versus-graft (HVG) responses, followed by stronger homeostatic contraction (days 10-12). The weaker day 10-12 GVH and HVG in females are followed by persistent donor T cell activation and increasing proliferation, expansion, and cytokine production from days 12 to 14. Lastly, greater female day 14 donor T cell engraftment, activation, and cytokine production were lost with in vivo IFN-γ neutralization from days 6 to 14. We conclude the following: 1) donor CD8 T cells enhance day 10 proliferation of donor CD4 T cells in both sexes; and 2) a weaker GVH/HVG in females allows prolonged survival of donor CD4 and CD8 T cells, allowing persistent activation. These results support the novel conclusion that sex-based differences in suboptimal donor CD8 CTL activation are critical for shaping sex-based differences in donor CD4 T cell engraftment at 2 wk and lupus-like disease long-term.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Graft vs Host Disease/immunology , Interferon-gamma/immunology , Animals , CD4-Positive T-Lymphocytes/metabolism , CD8-Positive T-Lymphocytes/metabolism , Cell Proliferation , Cell Transplantation/adverse effects , Cell Transplantation/methods , Chronic Disease , Cytokines/genetics , Cytokines/immunology , Cytokines/metabolism , Female , Flow Cytometry , Graft vs Host Disease/etiology , Graft vs Host Disease/metabolism , Host vs Graft Reaction/immunology , Interferon-gamma/genetics , Interferon-gamma/metabolism , Lupus Erythematosus, Systemic/immunology , Lymphocyte Activation/immunology , Male , Mice , Mice, Inbred DBA , Reverse Transcriptase Polymerase Chain Reaction , Sex Factors , Time Factors
7.
Clin Immunol ; 136(1): 61-73, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20451460

ABSTRACT

Lupus-like renal disease in DBA/2-into-F1 (DBA --> F1) mice is driven by donor CD4 T cells and is more severe in females. Donor CD8 T cells have no known role. As expected, we observed that females receiving unfractionated DBA splenocytes (CD8 intact --> F1) exhibited greater clinical and histological severities of renal disease at 13 weeks compared to males. Surprisingly, sex-based differences in renal disease severity were lost in CD8 depleted --> F1 mice due to an improvement in females and a worsening in males. CD8 intact --> F1 female mice exhibited significantly greater donor and host effector (CD44(hi), CD62L(lo)) CD4 T cells and ICOS(hi) CD4 T follicular helper cells than males. CD8 depleted --> F1 female mice exhibited a reduction in the absolute numbers of host, but not donor CD4 Tfh cells and lost the significant increase in host CD4 effector cells vs. males. Greater female IL-21 expression, a product of Tfh cells, was seen in CD8 intact --> F1 and although reduced was still greater than male CD8 depleted --> F1 mice. Thus, donor CD8 T cells have a critical role in mediating sex-based differences in lupus renal disease severity possibly through greater host ICOS(hi) CD4 T cell involvement.


Subject(s)
Antigens, Differentiation, T-Lymphocyte/metabolism , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Graft vs Host Disease/immunology , Interleukins/genetics , Lupus Nephritis/diagnosis , Sex Characteristics , Animals , Antibodies, Antinuclear/blood , Antigens, CD/metabolism , B-Lymphocytes/cytology , B-Lymphocytes/metabolism , Blood Urea Nitrogen , CD4-Positive T-Lymphocytes/cytology , CD4-Positive T-Lymphocytes/metabolism , CD4-Positive T-Lymphocytes/transplantation , CD8-Positive T-Lymphocytes/cytology , CD8-Positive T-Lymphocytes/transplantation , Cell Count , Cholesterol/blood , Female , Gene Expression/genetics , Gene Expression/immunology , Glomerulonephritis, Membranous/etiology , Glomerulonephritis, Membranous/immunology , Glomerulonephritis, Membranous/metabolism , Glomerulonephritis, Membranous/pathology , Graft vs Host Disease/blood , Graft vs Host Disease/complications , Graft vs Host Disease/pathology , Immunoglobulin G/metabolism , Inducible T-Cell Co-Stimulator Protein , Kidney/metabolism , Kidney/pathology , Kidney/ultrastructure , Lupus Nephritis/etiology , Lupus Nephritis/immunology , Lupus Nephritis/metabolism , Lupus Nephritis/pathology , Lymphocyte Depletion , Male , Mice , Mice, Inbred DBA , Mice, Inbred Strains , Proteinuria/diagnosis , Proteinuria/urine , Serum Albumin/metabolism , Spleen/cytology , Spleen/immunology , Spleen/metabolism , T-Lymphocytes/cytology , T-Lymphocytes/immunology , T-Lymphocytes/metabolism , T-Lymphocytes/transplantation , T-Lymphocytes, Helper-Inducer/cytology , T-Lymphocytes, Helper-Inducer/metabolism , Triglycerides/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...